FKS518
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FKS518, covering 2025-02-27 to 2025-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis [Phase 3]